Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemicbrain injury
J. Guan et al., Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemicbrain injury, BRAIN RES, 853(2), 2000, pp. 163-173
Insulin-like growth factor-1 (IGF-1) has been shown to be neuroprotective w
hen administered centrally following hypoxic-ischemic (HI) brain injury. Ho
wever, the cerebral distribution and site of action of IGF-1 after intracer
ebroventricular (i.c.v.) administration are not known. A unilateral HI brai
n injury was induced in adult rats by a modified Levine method. Either H-3-
IGF-1 alone, or in combination with unlabelled IGF-1, was administered into
the lateral ventricle 2 h after injury. The activity of 3H-IGF-1 signal in
the potentially injured cortex was compared between two treatment groups u
sing image analysis. The regional distribution and cellular localisation of
H-3-IGF-1 were examined autoradiographically in potentially injured hemisp
heres at 0.5 and 6 h after administration. Tritiated IGF-1 was detected pre
dominantly in the pia mater, perivascular spaces and subcortical white matt
er tracts 0.5 h after administration and decreased by 6 h (p < 0.05). The s
ignals associated with the perivascular spaces and pia mater were not block
ed by unlabelled IGF-1, suggesting non-saturable binding in these brain are
as. IGF-1 signal was co-localised with IGF binding protein (IGFBP)-2 immuno
staining in the white matter tracts where the signal was blocked by unlabel
led IGF-1, suggesting competitive association. IGF-1 signal associated with
neurons and glia was maximal in the cerebral cortex and less in the CA1-2
subregion of the hippocampus which were blocked by unlabelled IGF-1 (p < 0.
05). The signals from cortical neurons did not decrease 6 h after administr
ation, suggesting specific and persistent binding to these cells. Our resul
ts indicate that centrally administered IGF-1 can be translocated to neuron
s and glia via the perivascular circulation and the ependymal cell-white ma
tter tract pathways. (C) 2000 Elsevier Science B.V. All rights reserved.